期刊文献+

浅谈“大剂量131碘清除分化型甲状腺癌残灶”的早期并发症 被引量:2

下载PDF
导出
摘要 目的:探讨大剂量131碘清除分化型甲状腺癌残灶的早期并发症,以便更好的减少、预防131碘治疗后早期并发症的发生。资料:回顾了65例在我科行131碘治疗的分化型甲状腺癌患者。对发生的早期并发症进行统计,其中12例患者存在精神欠佳、乏力、嗜睡、头昏、心慌的一般状况;11例患者出现消化道反应;23例患者出现颈部水肿(NE);8例患者出现放射性甲状腺炎(RT);4例患者出现放射性涎腺炎。结论:大剂量131碘治疗分化型甲状腺癌是十分安全、有效的治疗手段,但需要采取必要的预防措施,尽量减少早期并发症的发生,提高患者的生活质量。
出处 《中国中医药咨讯》 2011年第11期28-28,共1页
  • 相关文献

参考文献8

二级参考文献11

  • 1潘明志,谭天秩,黄雨梅.Sjogren’s Syndrome患者唾液腺功能的定量研究[J].华西医学,1995,10(4):380-382. 被引量:1
  • 2孙仲良,刁幼华.甲状腺功能亢进症[M].北京:人民出版社,2001:217-218.
  • 3黄宛.临床心电图学.5 版[M].北京:人民卫生出版社,2000:356-364.
  • 4Lin W Y,Clin Nucl Med,1996年,21卷,10期,780页
  • 5Bohuslasvizki KH,Brnner W,Lasmann S,et aL.Quantitative salivary gland scintigraphy in the diagnosis of parechymal damage after treatment with radioiodine [J].Nucl Med Communication,1996,17(7) :681-687.
  • 6Jnmng SM,Cho JY,Ryu KY,et al.An immunohistochemical study of Na^+/I-symporter in human thyroid tissue and salivary gland tissue [J].Endocrinology,1998,139(23):4416-4419.
  • 7Kenneth A,Matthew D,Leonard W,et al.The role of radioiodine in salivary gland dysfunction [J].J ENT-Ear Nose and Throat,2000,6(3) :321.
  • 8Adams BK,Attia HM,Parkar S.Salivary gland scintigraphy in sjogren's syndrome [J].Nuclear Medicine Communication,2003,24(10): 1011-1016.
  • 9Mehen C,Murat T,Reha A.Scintigraphy evaluation of salivary gland dysfunction in patients with thyroid cancer after radioiodine treatment [J] .J Clin Nucl Med,2002,27(11):767-771.
  • 10韩春起,李亚明,白景明,李德顺,罗锡圭.脑SPECT灌注显像定量分析脑血流的方法学探讨[J].中华核医学杂志,1999,19(2):114-115. 被引量:13

共引文献37

同被引文献22

  • 1孟琼,万崇华,罗家洪.癌症患者生命质量测定量表EORT CQLQ-C30的应用[J].中国行为医学科学,2005,14(3):273-274. 被引量:152
  • 2Schlumberger M, Sherman SI. Approach to the patient with advanced differentiated thyroid cancer[J]. EurJ Endocfinol, 2012,166(1) :5 - 11.
  • 3Singer S, Lincke T, Gamper E, et al. Quality of life in patients with thyroid cancer compared with the general population [ J ]. Thyroid, 2012,22(2) :117 - 124.
  • 4Nixon IJ, Ganly I, Shah JP. Thyroid cancer: surgery for the primary tumor[J]. Oral Oncol, 2013,49(7) :654 -658.
  • 5Goretzki PE, Schwarz K, Lammers B. Surgical therapy for thyroid gland malignancies[ J]. HNO, 2013,61 ( 1 ) :71 - 83.
  • 6Husson O, Haak HR, Oranje WA, et al. Health - related quality of life among thyroid cancer survivors:a systematic review[ J]. Clin Endo- crinol (Oxf), 2011,75(4) :544 -554.
  • 7Zheng X, Wei S, Han Y, et al. Papillary Microcarcinoma of the Thy-roid: Clinical Characteristics and BRAFV6OOE Mutational Status of 977 Cases[ J]. Annals of surgical oncology, 2013,20(7) :2266 -2273.
  • 8Domos|awski P, Lukieficzuk T, Kaliszewski K, et al. Safety and current achievements in thyroid surgery with neuromonitoring[ J]. Adv Clin Exp Med, 2013,22( 1 ) : 125 - 130.
  • 9Tabei F, Neshandar Asli I, Azizmohammadi Z, et al. Assessment of ra- dioiodine clearance in patients with differentiated thyroid cancer[ J ]. Ra- diat Prot Dosimetry, 2012,152(4) :323 -327.
  • 10Rivkees SA, Mazzaferri EL, Verburg FA, et al. The treatment of differ-entiated thyroid cancer in children:emphasis on surgical approach and radioactive iodine therapy[ J ]. Endocr Rev, 2011,32 ( 6 ) :798 - 826.

引证文献2

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部